CST4 and Renal insufficiency: The study conducted by Rua showed that EECP therapy could reduce serum cystatin by 0.06 mg/L (p < 0.001) and increase eGFR by 5.8 mL/min/1.73 m2; the effect was more significant in patients with renal insufficiency [18].